ArticleBiomedicines2024

Efficacy of Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors in Renal Anemia: Enhancing Erythropoiesis and Long-Term Outcomes in Patients with Chronic Kidney Disease.

Yukina Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.